Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...
She took Ozempic, now she can't eat without vomiting. Lawsuit claims the drug made her ill
Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: DXR), the global ...
Column: A federal appeals court hands the FDA a stupendous win in its battle against stem cell clinics
The FDA claimed these clinics were plying patients with an illegal drug derived from their stem cells. A federal court agrees ...
Emergency Doctor Worries Louisiana’s Law Classifying Abortion Meds as Controlled Substances Could Be Life-Threatening
A new law will go into effect in Louisiana on Oct. 1 that will classify two drugs—mifepristone and misoprostol, which are ...
Lousiana's Abortion Med Law Could Delay Life-Saving Care
A new law goes into effect in Louisiana on Oct. 1 that reclassifies mifepristone and misoprostol as "controlled dangerous ...
These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava, DJT, Wynn, HP Inc., Acadia Healthcare, and More
Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...
health.wusf.usf.edu23m
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
STAT50m
The FDA is ‘making sandwiches,’ ‘breakfast salad’ in DC, and what keeps us from choking on food
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...
Everyday Health22m
FDA Approves the First New Type of Schizophrenia Drug in Decades
Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle ...
Health Care Up on Session, Down on Week, Amid Regulatory Risk -- Health Care Roundup
Health-care companies ticked up, but lost ground during a generally positive week for the stock market amid fears about the implications of a tight presidential race for health-care regulation.